title: Drug Interactions - Neonatal Intensive Care Drug Manual
text: |
  Neonatal Intensive Care Drug Manual
  |
  bet | 311/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Drug Interactions
  |
  Tetanus Immune Globulin or Diphtheria Antitoxin, if used, should be given at a separate site, with a separate needle and syringe.
  Should not be given to infants or children on anticoagulant therapy unless the potential benefit clearly outweighs the risk of administration.
  Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs and corticosteroids (used in greater than physiologic doses), may reduce the immune response to vaccines.
  |
  Adverse Reactions
  |
  Common: Pain, inflammation, redness, injection site mass persisting for up to a few days.
  Uncommon: Headache, fever, lethargy, malaise, myalgia.
  Rare: Anaphylaxis, urticaria and peripheral neuropathy.
  Any serious or unexpected adverse event following immunisation should be reported promptly. Providers should use clinical judgment in deciding which adverse events to report and parents/carers should be encouraged to notify the immunisation service provider or health authorities of any untoward medical occurrence that follows immunisation. Each State/Territory has its own contact details for notification. Contact telephone number for NSW Public Health Unit is 1300 066 055.
  |
  Compatibility
  |
  |
  |
  |
  | |